Diabetes Care, Vol 17, Issue 11 1320-1329, Copyright © 1994 by American Diabetes Association
Hospital use among diabetic patients and the general population
S Aro, T Kangas, A Reunanen, M Salinto and V Koivisto
National Research & Development Centre for Welfare & Health, University of Helsinki, Finland.
OBJECTIVE--This register-based linkage study compared hospital use among
diabetic and nondiabetic populations. The study focused on overall use, use
by disease categories, and inpatient care caused by complications. RESEARCH
DESIGN AND METHODS--The patient data were derived from the Hospital
Discharge Register and the Central Drug Register in Finland. All
drug-treated diabetic patients and discharges of patients in a 3-year
period were included in the study. Hospital use was measured by inpatient
days, mean length of stay, and discharge rate. RESULTS--Among diabetic
patients were eligible for drug reimbursement, 14.2% had at least one
hospital stay because of diabetes in a year, while 50.7% had at least one
hospital stay for any cause. Only 12.4% of the nondiabetic population was
hospitalized annually. Patients with diabetes as the principal diagnosis
consumed about 3% of all inpatient days; patients who had diabetes either
as the principal or as a subsidiary diagnosis used 8.3%; and people who
were eligible for antidiabetic drug reimbursement used 13.3% of total
inpatient days. Among diabetic children, the risk for hospitalization was
6.5 times higher than among nondiabetic children. With advancing age,
causes other than diabetes increasingly dominated hospitalization among
diabetic patients. Inpatient days because of cardiovascular diseases were
1.6-18 times more common among diabetic patients than among nondiabetic
patients, depending on gender and age-group. Diabetic patients used many
more hospital inpatient days than did the nondiabetic population for a
number of other disease categories that are usually not related to
diabetes. CONCLUSIONS--Hospital use among diabetic patients is
substantially greater than that among the nondiabetic population, mainly
because of cardiovascular and microvascular complications, but also because
of diseases unrelated to diabetes.